Loading... Please wait...

Add to Wish List

Click the button below to add the Options Newsletter 02-1997 to your wish list.

Options Newsletter 02-1997

  • Image 1

Product Description

  • Editorial: Kessler Leaves FDA In A Cloud of Controversy
  • Hydrazine Sulfate: Russian Rocket Fuel or Effective Cancer Therapy?
  • FDA Stops Dr. Springer From Treating His Famous Patients
  • Burzynski On Trial
  • Dr. Coulter Presents Govallo Paper in London and Berlin
  • The Stockholm Protocol
  • BioPro Trial for Prostate Cancer
  • Senator Grassley Vows Support for Medical Treatments Act

Find Similar Products by Category

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Our Newsletter